USANA Q3 net loss of $6.5M; lowers FY25 EPS guidance to $0.78 from $1.50-$2.20

USANA HEALTH SCIENCES INC

2025-Q3 EPS reported $0.67 revenue$699,057,000

Net sales $214M (+7% YoY) but net loss -$6.5M vs +$10.6M prior year; adj. diluted EPS -$0.15.
Direct selling active customers down 14% to 388,000; Hiya subscribers 193,400 (down 3% sequentially).
FY25 guidance cut sharply: diluted EPS $0.78 (prev $1.50-$2.20); adj. diluted EPS $1.73 (prev $2.35-$3.00).
Effective tax rate jumped to 65% from 45%, causing ~$7.6M income tax expense adjustment in Q3.
Company expects $4.7M restructuring charge in Q4 to align costs with sales; cash $145M, no debt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.